ImmuCell Corp
NASDAQ:ICCC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kordsa Teknik Tekstil AS
IST:KORDS.E
|
TR |
|
A&D Holon Holdings Co Ltd
TSE:7745
|
JP |
|
Tarsons Products Ltd
NSE:TARSONS
|
IN |
|
O
|
Oceaneering International Inc
LSE:0KAN
|
US |
|
Hindustan Oil Exploration Company Ltd
NSE:HINDOILEXP
|
IN |
|
BroadBand Security Inc
TSE:4398
|
JP |
|
ENEOS Holdings Inc
TSE:5020
|
JP |
|
G
|
GFL Environmental Inc
NYSE:GFL
|
CA |
|
C
|
CaoCao Inc
HKEX:2643
|
CN |
|
LQR House Inc
NASDAQ:YHC
|
US |
|
E
|
Eurogroup Laminations SpA
MIL:EGLA
|
IT |
|
Companhia de Saneamento do Parana Sanepar
BOVESPA:SAPR4
|
BR |
|
V
|
Vistra Corp
SWB:0V6
|
US |
ImmuCell Corp
Stock-Based Compensation
ImmuCell Corp
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
ImmuCell Corp
NASDAQ:ICCC
|
Stock-Based Compensation
$261k
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Stock-Based Compensation
$955m
|
CAGR 3-Years
12%
|
CAGR 5-Years
5%
|
CAGR 10-Years
13%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Stock-Based Compensation
$894m
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Stock-Based Compensation
$494m
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Stock-Based Compensation
$685.9m
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Stock-Based Compensation
$993.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
18%
|
CAGR 10-Years
8%
|
|
ImmuCell Corp
Glance View
ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company is headquartered in Portland, Maine and currently employs 60 full-time employees. The firm is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. The company manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. The company expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens, as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The firm is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.
See Also
What is ImmuCell Corp's Stock-Based Compensation?
Stock-Based Compensation
261k
USD
Based on the financial report for Dec 31, 2025, ImmuCell Corp's Stock-Based Compensation amounts to 261k USD.
What is ImmuCell Corp's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
1%
Over the last year, the Stock-Based Compensation growth was -20%. The average annual Stock-Based Compensation growth rates for ImmuCell Corp have been -1% over the past three years , 1% over the past five years .
